Home > Archives for December 2007 > Page 7

Month: December 2007

WednesdayDec 26, 2007 10:47 am

Ecotality, Inc. (ETLY.OB) Subsidiary Uses Exclusive Patent Rights to Power Electric Vehicles

eTech, a wholly owned subsidiary of Ecotality (OTCBB: ETLY), operates out of Phoenix, Arizona. The company was formed in 1996 to develop advanced transportations systems for battery electric vehicles with hydrogen technologies. The eTech staff is made up of 15 technical and professional personnel with a combination of more than 100 years work experience and 30 years specifically dedicated to electric vehicles and vehicle infrastructure. eTech works in collaboration with Electric Transportation Applications (ETA), a sister company incorporated in 1989, to provide technical support and testing services for the electric vehicle industry. Together, the companies conduct research focused on battery…

Continue Reading

WednesdayDec 26, 2007 10:38 am

Reeds, Inc. (REED) Posts 2007 Forecast, Increase in Sales for the Year

Reeds, Inc. (NASDAQ: REED) recently announced its estimates for fiscal 2007, based on an increased sales force, expanded marketing effort and public guidance issued by management. The company anticipates sales for 2007 at $13.901 million, up from a prior 2007 estimate of $13.630 million, and a jump from $10.484 million reported in 2006. Though Reed’s gross margin of 18.98% was lower than that reported in 2006, it was an increase from a prior forecast of 17.97%; this is primarily because the company’s main co-pack production facility increased its prices. Reed’s also recently announced the expansion of its California facility which…

Continue Reading

WednesdayDec 26, 2007 9:46 am

Beacon Equity Featured Company: Advanced Viral Research Corp. (ADVR.OB)

Advanced Viral Research Corp. (ADVR.OB) is a biopharmaceutical company focused on improving the lives of patients by researching, developing and marketing innovative therapies for a range of serious disorders and diseases. The company is primarily committed to bringing its flagship product, AVR118, to patients. AVR118 appears to have the potential to stimulate the pro-inflammatory response needed to fight viral infections, including HIV, as well as reduce aberrant autoimmune-type inflammatory responses. In January of 2005, Advanced Viral Research Corp. reported the results from its Phase I/II clinical trial of AVR118 in patients with AIDS. The results demonstrated that the product has continued…

Continue Reading

WednesdayDec 26, 2007 8:56 am

Financial Services Exchange, Inc. Schedules Conference Starting the Last Day of Next Month

Financial Services Exchange’s next conference will take place from January 31 to February 2, 2008 at the Adophus Hotel in Dallas, Texas. The hotel chosen is minutes away from Dallas’ major businesses, entertainment centers, and historical sites. The entire hotel staff is committed to creating an exceptional experience for their guests. Financial Services Exchange conferences strive to connect companies with people who can help their businesses reach greater heights. The relationships established are a crucial part in any business considering today’s fast-paced market. Doing business with people you know results in better trust and better decisions. All presenting companies have 20-25…

Continue Reading

WednesdayDec 26, 2007 8:06 am

Beacon Equity Research Featured Company: Bridgetech Holdings International, Inc. (BGTH.PK)

Bridgetech Holdings International, Inc. (BGTH.PK) is focused on transferring Western medical technology to China, focusing mostly on oncology initially. The Company has operations based out of both the U.S. and out of China and is offering the latest medical technology, together with drugs, devices, and diagnostics for distribution throughout the nation. China's middle class is projected to increase from 250 million people in 2003 to over 600 million by 2020. As the middle class emerges, the demand for more sophisticated and readily available healthcare products will increase, proving companies such as Bridgetech Holdings International excellent opportunities to capitalize in a…

Continue Reading

WednesdayDec 26, 2007 7:58 am

Beacon Equity Featured Company: Callisto Pharmaceuticals, Inc. (AMEX: KAL)

Callisto Pharmaceuticals, Inc. (AMEX: KAL) is focused on developing new therapeutics that treat both cancer and gastrointestinal diseases. The Company’s management has extensive experience developing drugs for large pharmaceutical companies as well as smaller biotechnology companies. The Company currently has three drugs in development. Guanilib is in late pre-clinical development and was purposely designed for chronic constipation, constipation-predominant irritable bowel syndrome and inflammatory bowel disease. Atiprimod is small molecule drug drug taken orally which reveals a multiplicity of anti-cancer mechanistic activities. The drug is currently in Phase II development for advanced carcinoid cancer. L-Annamycin is a liposome nanoparticle formulation of…

Continue Reading

WednesdayDec 26, 2007 7:53 am

Beacon Equity Featured Company: Dermisonics Inc. (DMSI.OB)

Dermisonics Inc. (DMSI.OB) is a Pennsylvania based company focused on developing new and innovative drug delivery technologies. In Particular, the Company is engaged in alternative drug delivery systems for small and large molecule drugs. Advanced trasdermal drug delivery technologies create a non-invasive delivery method of macromolecular pharmaceutical formulations. The Company’s proprietary technology makes it possible to transfer drugs through the skin by applying a low-level ultrasonic wave. Dermisonics' business strategy includes partnering with pharmaceutical and healthcare companies that can provide financial support and assist in commercializing their products. Currently, the Company is focusing on existing FDA approved products for the…

Continue Reading

WednesdayDec 26, 2007 5:27 am

StockGuru Blog: Universal Energy (UVSE) – Looking for Happy New Year! A $73M Happy New Year!

December 26th, 2007 Stock Guru Profile Universal Energy - Blog - News East OMG is UVSE’s medium risk — high return well in Cameron Parish, Louisiana. East OMG drilling operations have reached a vertical depth of approximately 16,000 feet for a planned total vertical depth of 16,500 feet on December 23, 2007. Universal Energy Corp acquired its 17.5 percent working interest in the East OMG Prospect in August 2007. The financial impact of East OMG with potential reserves in excess of 59 Billion Cubic Feet Equivalent of gas valued at approximately $416,000,000 (or $7.05 a cubic foot) means or very…

Continue Reading

WednesdayDec 26, 2007 5:27 am

StockGuru Blog: Renhuang Pharmaceuticals, Inc. (RHGP): A Plan to Become a Leader in Pharmaceutical Business in China

Stock Guru Profile News Blogs Stock Guru Podcast Renhuang Pharmaceuticals, Inc. (RHGP) has a definitive plan and you can hear the CEO explain it step by step at our Stock Guru Podcast. The CEO of RHGP indicates in specific terms that his company is headed for the AMEX or the Nasdaq and with the stock trading at $2.00 today that maybe sooner than you think! He explains how he intends to get there: Number One: Raise brand awareness — they have a top time slot on CCTV’s evening news! Number Two: Focus on high value added profits with the higher…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .